GlassScriptPhysician profile
Jennifer Hall
NPI 1417022559
$2,007.40
in general payments reported to CMS, 2019-2025
21 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $276 · 2021: $215 · 2022: $362 · 2023: $189 · 2024: $195 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $480.84 | 2019-2025 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $357.07 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Genentech USA, INC. | $233.69 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.65 | 2019-2025 | |
| Genzyme Corporation | $168.67 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $88.23 | 2022-2025 | Dupixent |
| Baxter Healthcare | $55.62 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $50.64 | 2025 | Arikayce, Brinsupri |
| Electromed, INC. | $48.24 | 2024-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $46.60 | 2019-2021 | |
| Mylan Specialty L.P. | $39.16 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.91 | 2021 | |
| Amgen INC. | $25.94 | 2025 | Tezspire |
| Viatris Specialty LLC | $25.87 | 2025 | Yupelri |
| Genentech, INC. | $25.18 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $19.03 | 2024 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.12 | 2023 | Lifevest |
| La Jolla Pharmaceutical Company | $14.92 | 2022 | |
| Philips North America LLC | $14.31 | 2024 | (8874) Incourage |
| Pfizer INC. | $14.24 | 2025 | |
| Merck Sharp & Dohme LLC | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.